← Search & browse all drugs
RESPIRATORY SYSTEM › DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES › OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS › Glucocorticoids
flunisolide
R03BA03
Forms & Strengths
- Nasal spray: 29 mcg per spray (25 mL bottle)
- Inhalation aerosol: 250 mcg per actuation
Adult Dosing
- Allergic rhinitis: 2 sprays per nostril twice daily (total 116 mcg/nostril/day), or 1 spray 3 times daily
- Asthma (inhalation): 500 mcg (2 inhalations) twice daily; maximum 2000 mcg daily in severe cases
Pediatric Dosing
- Children 6-14 years (nasal): 1 spray per nostril 3 times daily or 2 sprays per nostril twice daily
- Children 6-15 years (inhalation): 250 mcg (1 inhalation) twice daily; maximum 750 mcg daily
Indications
- Management of seasonal or perennial rhinitis
- Maintenance treatment of asthma as prophylactic therapy in patients requiring chronic corticosteroid administration
Mechanism of Action
- Synthetic fluorinated corticosteroid with potent glucocorticoid and weak mineralocorticoid activity
- Suppresses inflammation by inhibiting multiple cell types (mast cells, eosinophils, neutrophils, macrophages, lymphocytes) and mediator production
Contraindications
- Primary treatment of status asthmaticus or other acute episodes of asthma requiring intensive measures
- Hypersensitivity to flunisolide or any component of the formulation
- Untreated systemic fungal, bacterial, or viral infections
Adverse Reactions
- Nasal irritation, burning, stinging, or dryness
- Epistaxis and blood-tinged nasal mucus
- Pharyngitis and oral candidiasis (inhalation)
- Dysphonia and hoarseness
- Headache and nausea
- Hypothalamic-pituitary-adrenal (HPA) axis suppression with high systemic absorption
Drug Interactions
- Strong CYP3A4 inhibitors (e.g., ritonavir, ketoconazole) may increase systemic corticosteroid exposure
- Ritonavir: coadministration may significantly increase plasma concentrations of flunisolide
- Immunizing agents: live vaccines may have decreased efficacy or increased risk of systemic infection due to immunosuppression
Curated Content: Needs Vetting Before Put to Clinical Use